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Abstract: An injectable hydrogel composite consisting of
oligo(poly(ethylene glycol)fumarate) (OPF) and gelatin
microparticles has been developed as a novel carrier sys-
tem for cells and growth factors. Rabbit marrow mesen-
chymal stem cells (MSCs) and gelatin microparticles (MPs)
loaded with insulin-like growth factor-1 (IGF-1), transform-
ing growth factor-b1 (TGF-b1), or a combination of both
growth factors were mixed with OPF, a poly(ethylene
glycol)-diacrylate crosslinker and the radical initiators
ammonium persulfate and N,N,N0,N0-tetramethylethylene-
diamine, and then crosslinked at 378C for 8 min to form
hydrogel composites. Hydrogel composites encapsulating
rabbit marrow MSCs and blank MPs served as controls. At
day 14, confocal ﬂuorescent images of OPF hydrogels
showed a strong aggregation of rabbit marrow MSCs
when encapsulated with IGF-1-loaded MPs with or with-
out TGF-b1-loaded MPs. Quantitative RT-PCR results
showed that rabbit marrow MSCs encapsulated with MPs
loaded with TGF-b1 or both TGF-b1 and IGF-1 had a sig-
niﬁcant increase in the expression of chondrocyte-speciﬁc
genes such as collagen type II and aggrecan at day 14 as
compared with the control group. Speciﬁcally, samples
with both TGF-b1-loaded MPs and IGF-1-loaded MPs
exhibited a 121 6 20-fold increase of type II collagen gene
expression and a 71 6 24-fold increase of aggrecan gene
expression after 14 days of in vitro culture as compared
with controls at day 0. These results suggest that hydrogel
composites based on OPF and gelatin microparticles have
great potential as carriers for MSCs and multiple growth
factors for cartilage tissue engineering applications.  2008
Wiley Periodicals, Inc. J Biomed Mater Res 88A: 889–897,
2009
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INTRODUCTION
Articular cartilage tissue is an avascular tissue
withstanding both compressive loads and friction in
the joint.1 The complicated structure of articular car-
tilage often leads to failure in self repair and necessi-
tates the need for intervention for the treatment of
cartilage defects. The use of mesenchymal stem cells
(MSCs) has been proposed as a promising cell ther-
apy to restore cartilage defects, since MSCs can be
expanded multiple times without losing their
capacity to differentiate into chondrocytes.2 How-
ever, the delivery of MSCs to cartilage defects still
remains a challenge.
To date, various types of scaffolds made of syn-
thetic or natural polymers have been examined to es-
tablish a favorable environment for chondrogenic
differentiation of MSCs.3–5 Hydrogels are especially
attractive for the delivery of MSCs as they can retain
a high amount of water, and thus facilitate the trans-
port of nutrients to cells encapsulated in hydrogel
scaffolds.1,6 In addition, the administration and
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release of bioactive factors required for differentia-
tion of MSCs are easily modulated by altering the
macromolecular structure of hydrogels.7 A novel
injectable and biodegradable oligo(poly(ethylene gly-
col)fumarate) (OPF) hydrogel has been studied for
the delivery of cells and growth factors for cartilage
tissue engineering applications.
Transforming growth factors-b1 (TGF-b1), known
to induce chondrogenic differentiation of MSCs, was
successfully incorporated into OPF hydrogel compo-
sites including gelatin microparticles (MPs) and
released in a controlled manner depending on the
crosslinking characteristics of the hydrogel compo-
sites.8 An in vitro study with OPF hydrogels encapsu-
lating chondrocytes and TGF-b1-loaded MPs showed
that TGF-b1 released from the MPs promoted cell
proliferation while cells maintained the chondrocytic
phenotype.9 In addition, when rabbit marrow MSCs
were encapsulated in hydrogels with TGF-b1-loaded
MPs, an upregulation of chondrocyte-speciﬁc genes
such as collagen type II and aggrecan was observed.10
OPF hydrogel composites were also used for the
delivery of IGF-1, known to increase colony forma-
tion and extracellular matrix production of chondro-
cytes7,11 along with TGF-b1.12 Moreover, bilayered
OPF hydrogels encapsulating gelatin microparticles
loaded with TGF-b1 and/or IGF-1 in each layer were
implanted into cartilage defects of rabbits and dem-
onstrated the potential of OPF hydrogel composites
as delivery vehicles for multiple growth factors.13
In this study, we investigated the encapsulation of
rabbit marrow MSCs in OPF hydrogel composites
containing gelatin microparticles loaded with TGF-
b1, IGF-1, or both TGF-b1 and IGF-1, and examined
the effect of dual growth factor delivery on the chon-
drogenic differentiation of encapsulated cells with
confocal microscopy, biochemical assays, and real-
time PCR.
MATERIALS AND METHODS
OPF synthesis and characterization
OPF was synthesized from fumaryl chloride and PEG of
nominal molecular weight 10,000 according to a previously
established method.14 Oligomer molecular weight was
determined by gel permeation chromatography (GPC;
Model 410; Waters, Milford, PA) using a refractive index de-
tector (n 5 3). Puriﬁed OPF was stored at 2208C and steri-
lized prior to use by exposure to ethylene oxide for 14 h.
Gelatin microparticle preparation
Gelatin microparticles were fabricated from acidic gela-
tin (Nitta Gelatin, Osaka, Japan) following established
procedures.9 Brieﬂy, a gelatin solution was prepared by
dissolving 5 g gelatin in 45 mL distilled and deionized
water (ddH2O) at 608C. Then, this solution was added
dropwise to 250 mL chilled olive oil while stirring at 500
rpm. After 30 min, 100 mL chilled acetone (48C) was
added to the emulsion. After an additional 60 min, the
microparticles were collected by ﬁltration and washed
with acetone. These microparticles were then crosslinked
in a 0.1 wt % Tween 80 (Sigma, St. Louis, MO) solution
with 10 mM glutaraldehyde (GA) (Sigma) while stirring at
500 rpm at 158C. After 15 h, crosslinked microparticles
were collected by ﬁltration, washed with ddH2O, and then
agitated in 25 mM glycine solution for 1 h to inactivate
any unreacted GA. These microparticles were collected by
ﬁltration, washed with ddH2O, and then lyophilized over-
night. Finally, dried microparticles were sieved to obtain
particles of 50–100 lm diameter and sterilized with ethyl-
ene oxide for 14 h.
Rabbit marrow MSC isolation and preculture
Rabbit marrow MSCs were isolated from the femur of 4-
week-old rabbits as previously described.2,10 Brieﬂy, after
anesthesia, rabbit bone marrow was collected into a 10-mL
syringe containing 5000 U of heparin. The bone marrow
was then ﬁltered through a cell strainer (40 lm) and cul-
tured in DMEM-LG supplemented medium containing
10% v/v fetal bovine serum (Gemini, Calabasas, CA),
250 lg/L fungizone, 100 mg/L ampicillin, and 50 mg/L
gentamicin (Invitrogen) for 2 weeks. In an effort to reduce
any interanimal variation, a pool of rabbit marrow MSCs
from a total of 6 rabbits were collected together, placed in
medium containing 20% FBS and 10% dimethyl sulfoxide
(DMSO), and cryopreserved in liquid nitrogen prior to
use. For experiments, cryopreserved cells were thawed at
378C, seeded in T-75 ﬂasks, and expanded for 14 days of
culture in DMEM supplemented medium containing 10%
v/v fetal bovine serum (Gemini), 250 lg/L fungizone,
100 mg/L ampicillin, and 50 mg/L gentamicin. Cells from
one preparation were used in all experiments and were
cultured up to passage three before the encapsulation
process.
Encapsulation of rabbit marrow MSCs and
gelatin microparticles
Before encapsulation, gelatin microparticles were steri-
lized with ethylene oxide for 14 h. Then, sterilized MPs
were loaded with either IGF-1 or TGF-b1 by immersing
them in aqueous solution containing either IGF-1 or TGF-
b1 at pH 7.4 and incubating them at 48C for 15 h accord-
ing to established methods.12 To achieve the ﬁnal concen-
tration of 10 ng TGF-b1/mL and 100 ng IGF-1/mL based
on the medium, 55 lL of aqueous solution with either
7.2 ng TGF-b1/lL or 72 ng IGF-1/lL were loaded into
11 mg of gelatin microparticles. Eleven milligrams of blank
MPs were also prepared.
Following this incubation period, isolated rabbit marrow
MSCs and gelatin microparticles were encapsulated in
crosslinked OPF. In a typical experiment, 0.1 g of OPF and
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0.05 g of the crosslinking agent poly(ethylene glycol) dia-
crylate (PEG-DA; nominal MW 3400, Nektar Therapeutics,
Huntsville, AL) were combined in 300 lL PBS and mixed
with 22 mg of microparticles partially swollen in 55 lL of
PBS containing 7.2 ng TGF-b1/lL and 55 lL of PBS con-
taining 72 ng IGF-1/lL. Equal volumes (46.8 lL) of the
thermal radical initiators, 25 mM ammonium persulfate
(APS) and 25 mM N,N,N0,N0-tetramethylethylenediamine
(TEMED) in PBS were then added. After this mixture was
vortexed, a 168-lL PBS suspension containing 6.7 million
cells was added to achieve a cell concentration of 10 mil-
lion cells/mL in the ﬁnal suspension. After gentle mixing,
the suspension was quickly injected into Teﬂon molds
(6 mm diameter, 1 mm thickness) followed by incubation
at 378C for 8 min. Final gel constructs were transferred
into a 12-well tissue culture plates containing 2.5 mL me-
dium in each well. The medium was changed every 3
days. At days 3, 7, and 14, samples were collected for bio-
chemical assays (n 5 4), quantitative reverse transcriptase-
polymerase chain reaction (RT-PCR) (n 5 4), and histologi-
cal analysis (n 5 2). Samples at day 0 were collected im-
mediately after the encapsulation process and used as a
control for RT-PCR. To compare the effect of dual growth
factor delivery to that of single growth factor delivery on
encapsulated rabbit marrow MSCs, hydrogel composites
encapsulating either IGF-1-loaded MPs or TGF-b1-loaded
MPs were also prepared. Additionally, hydrogel compo-
sites with blank MPs were also prepared at each time
point.
Confocal ﬂuorescence microscopy
Confocal ﬂuorescence microscopy (Zeiss LSM 510,
Thornwood, NY) was used to visualize rabbit marrow
MSCs encapsulated in OPF hydrogel composites at day 14.
Speciﬁcally, rabbit marrow MSCs complexed with a Live/
Dead reagent (combination of 4 lM ethidium homodimer-
1 (EthD-1) and 2 lM calcein acetoxymethyl ester (calcein
AM) were excited using a 488 nm laser, and images were
collected using emission from a 500–550 nm bandpass ﬁl-
ter for Live staining and a 650 nm long pass ﬁlter for
Dead staining with a resolution of 103. To visualize cell
morphology in hydrogels, samples were stained with rho-
damine phalloidin for 1 h in the incubator after being
rinsed with PBS and incubated with 0.5% Triton for
30 min. Then, samples were excited using a 540 nm laser
and images were collected using emission from a 565 nm
long pass ﬁlter with a resolution of 203. Three dimen-
sional images of rabbit marrow MSCs were also collected
using a series of Z optical sections. The thickness between
each section was 25 lm and the projection images were
acquired by overlapping each slice in the z sections using
Zeiss Aim software. Single hydrogel constructs were ana-
lyzed for each group examined.
DNA assay
At each time point, samples and cell-free hydrogels
were removed from medium, rinsed in 2 mL PBS, homog-
enized with a pellet grinder (Fisher Scientiﬁc), and
digested in 500 lL of a proteinase K solution (1 mg/mL
proteinase K (Sigma-Aldrich), 10 lg/mL pepstatin A
(Sigma-Aldrich), and 185 lg/mL iodoacetamide (Sigma-
Aldrich) in tris-EDTA solution (6.055 mg/mL Tris(hydrox-
ymethyl aminomethane) (Sigma-Aldrich), 0.372 mg/mL
EDTA (Sigma-Aldrich), pH 7.6 adjusted by HCl) at 608C
for 16 h. After collection and digestion of all samples and
cell-free hydrogels, specimens underwent three repetitions
of a freeze/thaw/sonication cycle (30 min at 2808C,
30 min at room temperature, 30 min of sonication) for
complete extraction of DNA from the cell cytoplasm. DNA
assays were then run for each experimental and control
group at each time point. DNA content was calculated by
measuring double-stranded DNA content using the Pico-
Green assay (Molecular Probes, Eugene, OR) according to
the manufacturer’s instructions. The ﬂuorescence of cell-
free hydrogels was subtracted from the ﬂuorescence values
of experimental groups to account for ﬂuorescence of the
material alone.
Quantitative RT-PCR for gene expression
Total RNA was extracted from hydrogel composites at
each time point via the RNeasy Mini Kit (Qiagen, Hilden,
Germany). Brieﬂy, hydrogels were transferred into RNA
lysis buffer solution and homogenized by gentle pipetting.
The homogenized solution was puriﬁed using a Qiagen
shredder column and total RNA was extracted with the
RNeasy Mini Kit. RNA samples were then reverse-tran-
scribed to cDNA using Oligo dT primers and superscript
III transcriptase. The ﬁnal cDNA was then subjected to
real-time PCR (ABI Biomed 7300 Real-Time PCR System)
to determine the expression of genes for type II collagen
genes, aggrecan, and type I collagen. The results from real-
time quantitative PCR were analyzed by relative quantiﬁ-
cation.15 Relative quantiﬁcation compares the PCR signals
of a gene of interest in a treatment group to that of an
untreated control (the control can be the value at time zero
for a time-course study) after the gene of interest is nor-
malized to a housekeeping gene. For these studies, glycer-
aldehyde-3-phosphatase dehydrogenase (GAPDH) was
used as the housekeeping gene, and OPF hydrogel compo-
sites with blank MPs encapsulating rabbit marrow MSCs
immediately after encapsulation (day 0) were used as the
control group. The sequence of primers for GAPDH, type I
collagen, type II collagen, and aggrecan were as follows:
GAPDH: 5-TCACCATCTTCCAGGAGCGA-3, 5-CACAAT
GCCGAAGTGGTCGT-3; type I collagen gene: 5-CTTCTG
GCCCTGCTGGAAAGGATG-3, 5-CCCGGATACAGGTTTC
GCCAGTAG-3; type II collagen gene: 50-AACACTGCCA
ACGTCCAGAT-30, 50-CTGCAGCACGGTATAGGTGA-30;
Aggrecan: 50-GCTACGGAGACAAGGATGAGTTC-30, 50-
CGTAAAAGACCTCACCCTCCAT-30.
GAG assay
Glycosaminoglycan (GAG) content was determined
using a biochemical assay, the dimethylmethylene blue
dye (DMMB) assay (Sigma-Aldrich), as previously
described.16 Samples prepared for DNA assay were used
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for GAG assay, and GAG/DNA content was measured for
each sample. Upon DMMB binding to GAG, a pink color
is produced that allows for quantiﬁcation of GAG by
measuring absorbance at 520 nm. GAG content in hydro-
gels was calculated by comparison to a curve generated
from standards of known amounts of chondroitin sulfate
(Sigma-Aldrich). A microplate reader (BIO-TEK Instru-
ment, Winooski, VT) was utilized for both the absorbance
and ﬂuorescence measurements.
Histology
Histology samples were prepared as previously
described.9 Brieﬂy, samples from each time point were
rinsed in 2 mL PBS for 1 h and then ﬁxed in 10% neutral
buffered formalin (Sigma-Aldrich). After ﬁxation, these
samples were dehydrated by immersion in a series of etha-
nol solutions (70, 80, 85, 90, 95, and 100%) and xylene solu-
tions in ethanol (50 and 100%). Specimens were then em-
bedded in parafﬁn and cross-sectioned to a thickness of
20 lm using a microtome (Microm, Walldorf, Germany).
Sections from all groups were simultaneously stained with
Safranin-O. Images were acquired with a light microscope
(Eclipse E600; Nikon, Melvile, NY) equipped with a video
camera (3CCD Color Video Camera DXC-950P; Sony, Park
Ridge, NJ).
Statistical analysis
DNA, GAG, and gene expression are reported as means
6 SD. Repetitive ANOVA and Tukey’s multiple compari-
son tests were used to determine possible signiﬁcant dif-
ferences (p < 0.05) in the DNA and GAG contents for each
group.
RESULTS
OPF hydrogel composites were previously exam-
ined as an injectable carrier for delivery of both
TGF-b1 and IGF-1 to cartilage defects.12,17 In vitro
release kinetics data showed that both growth factors
exhibited a similar burst release in PBS when they
were incorporated into acidic gelatin micropar-
ticles.12 Acidic gelatin microparticles loaded with
IGF-1 had an approximate cumulative burst release
of 22% after 3 days and an approximate cumulative
release of 32% after 28 days, while the corresponding
cumulative releases for TGF-b1 were 26% after
3 days and 45% after 28 days.12 When microparticles
loaded with growth factors were encapsulated
within OPF hydrogels, an increased retention of the
growth factors was observed as compared with both
nonencapsulated loaded microparticles and OPF
hydrogels loaded with growth factors in the absence
of microparticles.12 Accordingly, this study was
designed to assess the effects of dual growth factor
delivery on rabbit MSCs encapsulated in hydrogel
composites including microparticles loaded with
TGF-b1, IGF-1, or their combination.
Confocal ﬂuorescence microscopy
At 14 days, the viability and distribution of encap-
sulated rabbit marrow MSCs were qualitatively
examined by confocal ﬂuorescence microscopy. Cells
were stained with Live/Dead assay kit containing
calcein AM and ethidium homodimer-1 for cell via-
bility and distribution [Fig. 1(A–C)]. Calcein AM
stains live cells with green ﬂuorescence, and ethi-
dium homodimer-1 stains dead cells with red ﬂuo-
rescence. Cells were also stained with rhodamine
phalloidin to visualize cell morphology in hydrogel
composites [Fig. 1(D–F)]. As shown in Figure 1(A–
C), when rabbit marrow MSCs (green color) were
encapsulated in OPF hydrogel composites, they were
well distributed throughout the hydrogel. An appa-
rent increase in the aggregation of rabbit marrow
MSCs was noted in groups containing IGF-1-loaded
MPs [Fig. 1(B,C)]. Figure 1(D–F) also shows that
most of the rabbit marrow MSCs maintained their
round morphology. The aggregation of rabbit mar-
row MSCs is also shown in a Z-axial projection
image for a hydrogel composite containing both
TGF-b1-loaded MPs and IGF-1-loaded MPs after
staining with rhodamine phalloidin (Fig. 2).
DNA assay
DNA content at each time point is depicted in Fig-
ure 3. All the groups exhibited a similar decrease in
DNA content after 14 days. Groups containing TGF-
b1-loaded MPs had a signiﬁcant decrease in DNA
content starting at day 7 and a signiﬁcant difference
when compared with other groups at day 14.
Quantitative gene expression analysis
Quantitative gene expressions for collagen type II,
aggrecan, and collagen type I were measured by
real-time RT-PCR to assess the expression of chon-
drocyte-speciﬁc genes of encapsulated rabbit marrow
MSCs. As shown in Figure 4(A), gene expression for
collagen type II followed an increasing trend at day
14 for all groups as compared with the control group
(no growth factor at day 0). However, the highest
increase in collagen type II gene expression was
found in cells encapsulated in hydrogel composites
containing TGF-b1-loaded MPs and both TGF-b1-
loaded MPs and IGF-1-loaded MPs. At day 14,
hydrogel composites containing TGF-b1-loaded MPs
and both TGF-b1-loaded MPs and IGF-1-loaded MPs
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Figure 1. Confocal ﬂuorescence microscopy images of rabbit marrow MSCs encapsulated in OPF hydrogel composites at
day 14. Images show rabbit marrow MSCs stained with Live/Dead assay reagents (calcein AM and EthD-1) in (A) OPF
hydrogel composites with blank MPs, (B) OPF hydrogel composites with IGF-1-loaded MPs, and (C) OPF hydrogel com-
posites with both IGF-1-loaded MPs and TGF-b1-loaded MPs. Additional images are for rabbit marrow MSCs stained
with rhodamine phalloidin in (D) OPF hydrogel composites with blank MPs, (E) OPF hydrogel composites with IGF-1-
loaded MPs, and (F) OPF hydrogel composites with both IGF-1-loaded MPs and TGF-b1-loaded MPs. Scale bar represents
100 lm. Arrows indicate rabbit marrow MSCs in OPF hydrogel composites. [Color ﬁgure can be viewed in the online
issue, which is available at www.interscience.wiley.com.]
Figure 2. 2D image (A) and z-axial projection stack image (B) of rabbit marrow MSCs in OPF hydrogel composites with
both IGF-1-loaded MPs and TGF-b1-loaded MPs at day 14. Samples were incubated with rhodamine phalloidin solution
for 1 h and imaged with confocal ﬂuorescence microscopy. Scale bar represents 100 lm. Small arrows indicate rabbit mar-
row MSCs and large arrows indicate MPs in hydrogel composites. [Color ﬁgure can be viewed in the online issue, which
is available at www.interscience.wiley.com.]
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exhibited 121 6 37-fold increase and 122 6 20-fold
increase in collagen type II gene expression, respec-
tively, when compared with controls.
A signiﬁcant increase in aggrecan gene expression
was observed in groups with TGF-b1-loaded MPs.
Aggrecan expression showed 75 6 66-fold increase
in groups containing TGF-b1-loaded MPs and 71 6
24-fold increase in groups containing both TGF-b1-
loaded MPs and IGF-1-loaded MPs after 14 days
when compared with controls [Fig. 4(B)]. The expres-
sion of collagen type I was not signiﬁcantly different
across the culture period except for groups contain-
ing IGF-1-loaded MPs only [Fig. 4(C)]. However, in
all cases, the fold increases of expression for collagen
type I was negligible when compared with the corre-
sponding values for collagen type II and aggrecan.
GAG assay and histology
As shown in Figure 5, GAG results showed that
no signiﬁcant differences in GAG/DNA content
were found between all groups during the 14-day
culture period.
The presence of GAG within cell constructs was
visualized by Safranin-O staining. Figure 6 displays
cross sections of these constructs at days 0 and 14.
Rabbit marrow MSCs (noted by small arrows) and
gelatin microparticles (noted by large arrows) were
clearly stained with a deep red. Because of the dif-
ferent swelling properties of the OPF hydrogel and
the gelatin microparticles, the preparation of samples
for histology resulted in tearing of some samples.
Similar to confocal ﬂuorescence microscopy results,
cells and MPs were homogenously distributed
throughout hydrogel composites, and larger cell
aggregates were observed in sections of OPF hydro-
gel composites containing IGF-1-loaded MPs than in
sections of OPF hydrogel composites devoid of IGF-
1-loaded MPs. However, no apparent differences in
GAG staining were found between groups at day 14.
Figure 3. DNA content of OPF hydrogel composites
encapsulating rabbit marrow MSCs/blank MPs (No GFs),
rabbit marrow MSCs/IGF-1-loaded MPs (IGF-1), rabbit
marrow MSCs/TGF-b1-loaded MPs (TGF-b1), or rabbit
marrow MSCs/both IGF-1-loaded MPs and TGF-b1-loaded
MPs (IGF-1 þ TGF-b1) over a 14-day culture period. Sam-
ples marked by (*) exhibited signiﬁcantly lower DNA con-
tent as compared with the same sample type at day 3 (p <
0.05). The symbol (#) indicates a signiﬁcant difference in
DNA content as compared with the other groups at the
same time point (p < 0.05). Error bars represent means 6
SD with n 5 4.
Figure 4. Quantitative analysis of (A) collagen type II, (B)
aggrecan, (C) collagen type I gene expression by rabbit
marrow MSCs encapsulated in OPF hydrogel composites
with blank MPs (No GFs), IGF-1-loaded MPs (IGF-1), TGF-
b1-loaded MPs (TGF-b1), or both IGF-1-loaded MPs and
TGF-b1-loaded MPs (IGF-1 þ TGF-b1) over a 14-day cul-
ture period. Data are presented as a fold ratio after nor-
malization to GAPDH values. The expression level of con-
trols (day 0) is represented as 1. Within a given hydrogel
formulation, signiﬁcantly higher (p < 0.05) gene expression
than the day 0 value (control) is noted with (*). Samples
indicated with (#) had signiﬁcantly higher gene expression
than the other two groups at the same time point (p <
0.05). Error bars represent means 6 SD for n 5 4.
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DISCUSSION
Several studies have reported that the combination
of IGF-1 and TGF-b1 promotes in vitro chondrogenic
differentiation of MSCs while maintaining their pro-
liferation and GAG production.18,19 However, sur-
prisingly, the dual delivery of IGF-1 and TGF-b1 via
OPF hydrogel composites did not improve cartilage
formation when they were used for the repair of
osteochondral defects in a rabbit model.13 Based on
this observation, this study was designed to assess
the combined effect of these growth factors (TGF-b1
and IGF-1) loaded into gelatin microparticles on the
chondrogenic differentiation of rabbit marrow MSCs
embedded in OPF hydrogels in vitro. For this study,
four different groups were tested as follows: rabbit
marrow MSCs and blank MPs encapsulated in OPF,
rabbit marrow MSCs and IGF-1-loaded MPs encap-
sulated in OPF, rabbit marrow MSCs and TGF-b1-
loaded MPs encapsulated in OPF, and rabbit mar-
row MSCs and both IGF-1-loaded MPs and TGF-b1-
loaded MPs encapsulated in OPF. The cell seeding
density was 10 million cells/mL expressed in mar-
row MSCs per unit volume of the ﬁnal hydrogel.
The growth factor loading concentrations were 10
and 100 ng/mL for TGF-b1 and IGF-1, respectively.
The release kinetics of both growth factors from OPF
hydrogel composites incorporating gelatin micropar-
ticles of the same composition as that examined in
this study and prepared by crosslinking of the same
type of OPF macromer as studied here, but with a
Figure 5. GAG/DNA content of OPF hydrogel compo-
sites encapsulating rabbit marrow MSCs/blank MPs (No
GFs), rabbit marrow MSCs/IGF-1-loaded MPs (IGF-1), rab-
bit marrow MSCs/TGF-b1-loaded MPs (TGF-b1), or rabbit
marrow MSCs/both IGF-1-loaded MPs and TGF-b1-loaded
MPs (IGF-1 þ TGF-b1) over a 14-day culture period. No
signiﬁcant differences in GAG/DNA content were found
between or within groups over the culture period. Error
bars represent means 6 SD for n 5 4.
Figure 6. Cross-sections of OPF hydrogel composites encapsulating rabbit marrow MSCs/both IGF-1-loaded MPs and
TGF-b1-loaded MPs at day 0 (A), rabbit marrow MSCs/blank MPs at day 14 (B), rabbit marrow MSCs/ IGF-1-loaded MPs
at day 14 (C), or rabbit marrow MSCs/both IGF-1-loaded MPs and TGF-b1-loaded MPs at day 14 (D). Sections were
stained with Safranin-O. Small arrows indicate rabbit marrow MSCs and large arrows indicate MPs in hydrogel compo-
sites. Scale bar represents 100 lm. [Color ﬁgure can be viewed in the online issue, which is available at www.interscience.
wiley.com.]
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different crosslinking agent has been previously
investigated, however, in the absence of any encap-
sulated cells.9,12 Although we recognize that the
presence of encapsulated cells may affect the release
kinetics of growth factors, the results of the previous
studies can provide an estimate of the growth factor
release proﬁles and local concentrations experienced
by encapsulated cells.
A qualitative assessment of encapsulated cell mor-
phology and aggregation was conducted at day 14
by confocal laser scanning microscopy after staining
with calcein AM and ethidium homodimer-1. Cal-
cein AM stains live cells with green ﬂuorescence and
ethidium homodimer-1 stains dead cells with red
ﬂuorescence. As seen in Figure 1, live rabbit marrow
MSCs were distributed throughout OPF hydrogels
with a sparse distribution of dead rabbit marrow
MSCs. Interestingly, rabbit marrow MSCs coencap-
sulated with IGF-1-loaded MPs showed a tendency
for cell aggregation [Fig. 1(B,C)], while rabbit mar-
row MSCs encapsulated without IGF-1-loaded MPs
formed small clusters [Fig. 1(A)], suggesting that
release of IGF-1 promoted the aggregation of rabbit
marrow MSCs. The importance of strong cell–cell
interaction and spherical morphology for chondro-
genesis of MSCs has been previously reported.
Strong cell–cell interactions mediated by N-cadherin
and integrins convert MSCs into prechondroblasts at
the early mesenchymal condensation stage during
limb development.20,21 This aggregation could be
due to cell migration in OPF hydrogels rather than
cell proliferation, since DNA assay results showed
no increase in DNA content by day 14. Another ex-
planation of the cell aggregation could be that the
proliferation of MSCs was limited in a speciﬁc area
in the hydrogels with concomitant death of cells in
other regions, related to an increased concentration
of IGF-1 in particular areas. This cell aggregation
was more evident around gelatin microparticles. Fig-
ure 2 shows the z-axial projection stack image of rab-
bit marrow MSCs around gelatin microparticles. As
shown in Figure 2(B), rabbit marrow MSCs appeared
to attach to the surface of gelatin microparticles.
However, rabbit marrow MSCs did not show the
typical cell spreading shown by cells cultured in 2D
plates. This result indicates that although gelatin
microparticles provide sites for cell attachment, the
OPF hydrogel surrounding them enables them to
maintain their round morphology.
Results of the DNA assay showed a decrease in
DNA content in all groups over the culture period,
indicating that cell death may have occurred during
the encapsulation process.9,22 A previous study with
rabbit marrow MSCs showed a similar decrease of
DNA content when encapsulated in OPF hydro-
gels.10 The highest decrease of DNA content was
found in groups treated with TGF-b1, suggesting
that IGF-1 inhibited cell death in OPF hydrogel
composites.
To examine the chondrogenic differentiation of
rabbit marrow MSCs, the relative gene expressions
of collagen type II, aggrecan, and collagen type I
were analyzed. Collagen type II and aggrecan gene
expression are markers of chondrogenic differentia-
tion of MSCs, while collagen type I gene is mainly
expressed by ﬁbroblasts and other cell types.23 Gene
expression was normalized to a housekeeping gene
and expressed as a fold ratio as compared with the
gene expression of control samples prepared at day
0 (rabbit marrow MSCs and blank MPs). At day 14,
the highest increase in collagen type II expression
was found in groups containing TGF-b1-loaded MPs
with or without IGF-1-loaded MPs [Fig. 4(A)]. How-
ever, the incorporation of IGF-1-loaded MPs did not
promote collagen II gene expression of rabbit mar-
row MSCs as compared with groups containing
TGF-b1-loaded MPs only. Aggrecan expression also
showed a similar result as follows: a signiﬁcant
increase in aggrecan gene expression was found in
groups with TGF-b1-loaded MPs at day 14 regard-
less of the presence of IGF-1-loaded MPs [Fig. 4(B)].
These results suggest that TGF-b1 mainly contrib-
uted to the upregulation of chondrocyte-speciﬁc
genes for rabbit MSCs encapsulated in OPF hydrogel
composites, even though IGF-1-loaded MPs pro-
moted the cell aggregation.
The production of GAGs, which are associated
with the chondrocytic phenotype of cultured cells,
was also measured to examine the chondrogenic dif-
ferentiation of rabbit marrow MSCs. As shown in
Figure 5, the amount of GAG/DNA content was
5 lg/lg which is similar to that in other studies
using rabbit MSCs for culture periods of 2 weeks24,25;
however, no signiﬁcant differences in GAG/DNA
content were found between groups over the culture
period. In accordance with these measurements,
although histology images (Fig. 6) demonstrated
rounded rabbit marrow MSCs during the culture pe-
riod and strong cell aggregation in groups with IGF-
1-loaded MPs at day 14, there were no differences in
GAG staining between groups at day 14. Contrary to
our expectation, the incorporation of IGF-1-loaded
MPs did not promote GAG production. This result
may be due to the low concentration of IGF-1 loaded
into the gelatin microparticles. In this experiment,
IGF-1 was used only for loading MPs unlike other
studies in which medium containing 100 ng/mL
IGF-1 was changed every 2 or 3 days.19 Since TGF-
b1 and IGF-1 promoted the upregulation of chondro-
cyte-speciﬁc genes and cell aggregation, respectively,
one cannot assume a substantial decrease in the ac-
tivity of loaded growth factors during the culture pe-
riod. Alternatively, rabbit marrow MSCs of passage
three might not be able to produce as much ECM as
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chondrocytes in vitro without further treatments
even if they exhibited chondrocyte speciﬁc gene
expression.
CONCLUSION
Rabbit marrow MSCs encapsulated in OPF hydro-
gels with IGF-1-loaded MPs, TGF- b1-loaded MPs,
or the combination of both remained viable and
maintained a round morphology over a 14-day cul-
ture period. The presence of IGF-1-loaded MPs pro-
moted the aggregation of rabbit marrow MSCs
within the hydrogels. Additionally, when rabbit mar-
row MSCs were encapsulated with microparticles
loaded with TGF-b1, the cells exhibited an upregula-
tion of chondrocyte-speciﬁc genes such as collagen
type II and aggrecan. These results suggest that both
IGF-1 and TGF-b1 loaded into gelatin microparticles
were effectively delivered to rabbit MSCs encapsu-
lated in hydrogel composites to promote the upregu-
lation of chondrocyte-speciﬁc genes.
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